A3P

Log in

Eurofins strengthens in clinical analysis in Italy

The French group of biopharmaceutical, environmental and food analysis services Eurofins announced on Tuesday the acquisition of the Italian company Genoma Group, specializing in clinical tests.

Read more...

Many "anomalies" detected in cosmetics sold in France

Non-compliant labeling, allegations or compositions: the Directorate-General for Competition, Consumer Affairs and Fraud Control (DGCCRF) identified numerous "anomalies" in its 2016 survey on cosmetics, according to a report Released on Friday.

Read more...

Ipsen treatment gets a new indication in the US

Dysport, a drug of the French pharmaceutical group Ipsen against spasticity, now enjoys a new marketing authorization in the United States to treat the lower limbs in adults, the group said Friday.

Read more...

Discovery of an effective antibiotic against resistant bacteria

Scientists have discovered in a soil sample taken in Italy a new antibiotic, which is effective against bacteria resistant to known antimicrobials.

Read more...

Sanofi wants to become a champion of bioproduction drugs

Sanofi has lately embraced the biotechnological revolution, but is accelerating to catch up: after 3,3 billion of industrial investments in this field in the last five years, it plans to spend about 600 million euros per year by 2020.

Read more...

a3p-100pxhaut logo

 fren

Commit to share
Transmit and progress together
Promoting innovation

The A3P Association is a major player in the pharmaceutical and biotechnology industry.
Created in 1986, it contributes to the good development of the production of medicines and clean and sterile equipment, it runs a network of professionals 21 000, manufacturers and suppliers, as part of International Congress and technical days.

It now has over 1700 members who share their technical experience, scientific and regulatory.

More info on video (Versiongb here )


  group    administrators A3P
    
& Project Managers

letter   newsletter A3P